The work, led by Andrea C. Betts of the University of Texas Health Science Center at Houston together with the AYA National Standards for Cancer Survivorship Care Consortium, synthesizes lessons from five studies funded by the National Cancer Institute. The studies spanned nine health care systems across seven states—California, Florida, Minnesota, New Jersey, New York, Texas, and Washington—including seven NCI-designated comprehensive cancer centers, a large integrated health care system, and a county safety-net hospital. Using retrospective cohort and mixed-methods designs, the teams mined electronic health records, surveyed AYAs, clinicians, and administrators, and conducted in-depth interviews and focus groups with survivors diagnosed between 2014 and 2024, aged 15 to 44 at diagnosis, predominantly female, and racially and ethnically diverse. Their cancers reflected the typical AYA spectrum: brain tumors, breast and colorectal cancer, gynecologic malignancies, leukemia, lymphoma, melanoma, sarcomas, testicular and thyroid cancers.

The benchmark against which all of this care was measured is the new National Standards for Cancer Survivorship Care, a framework that defines the essential components of a survivorship program—from screening for late effects to psychosocial assessment and referrals to supportive services. On paper, many of the standards look tailor-made for measurement through structured electronic health record data. Take the recommendation to assess emotional and psychological effects of cancer and refer patients for treatment when needed. In theory, an evaluator could simply count documented screenings for depression, anxiety, or distress, categorize the scores, and track referrals to behavioral health for patients whose scores crossed a threshold. In practice, the researchers found, that seemingly simple pathway is riddled with hidden decision points that can quietly distort the picture of care.

The first and most formidable challenge is simply identifying a longitudinal cohort of AYA survivors inside the record system. This is a population in constant motion. Survivors change insurance plans, move across state lines, and bounce between pediatric and adult care, oncology and primary care. A young woman might receive her diagnosis and treatment at an academic cancer center, undergo maintenance therapy at a community cancer center after relocating, and eventually land in a primary care practice where the original cancer diagnosis is lost or altered in the record. If a survivor cannot be reliably identified, she cannot be counted—and if she cannot be counted, the quality of the care she receives cannot be assessed.

Even when a survivor is successfully identified, the data available to any single institution are fragmentary. If the academic cancer center that treated the initial tumor tries to evaluate distress screening rates among its AYA population, its electronic health record contains no information about what happened after the survivor transferred elsewhere. The assessment is truncated at the moment of the care switch—and unless the evaluation team can detect that the switch occurred, the survivor may be incorrectly recorded as never having been screened. Defining denominators, the pool of patients eligible for a recommended service, poses its own problems. Fertility service referral, a near-universal recommendation for this population, illustrates the trap: a referral may be documented, but whether the patient actually saw a fertility specialist in a different system, declined the service, was unable to afford it, or was never offered it may live only in free-text visit notes, invisible to structured queries. Capturing true outcomes, the authors conclude, likely requires linking records to claims data, surveys, and qualitative sources.

The human side of the measurement problem proved just as thorny. AYAs themselves often have limited awareness of what survivorship care even is, shaped by developmental stage, competing life priorities such as school and work, and inconsistent communication across the many settings they pass through. Many have little prior experience navigating the health care system and report diagnostic delays and access struggles that erode their confidence that their complex needs will be met. Clinicians, meanwhile, operate under fundamentally different models: pediatric oncology is family-centered and multidisciplinary, while adult oncology places the burden of navigation squarely on the patient. The field also lacks validated patient-reported outcome and experience measures that span the full developmental range of the AYA population, undermining comparability across studies and systems.

Strikingly, the studies found that clinicians’ and administrators’ perceptions of the survivorship care being delivered diverged from what AYAs themselves reported receiving. Survivors described a deficit of evaluation on issues that matter most to them—financial concerns, insurance worries, fertility—and in qualitative interviews they described poor coordination across health systems and a sense of being personally responsible for driving communication between providers just to obtain needed care. Clinicians and administrators, for their part, endorsed the importance of evaluation under the new standards but pointed to implementation barriers, including the geographic mobility and fragmented care that make AYAs so hard to follow in the first place.

There is also a deeper conceptual tension. The survivorship standards were designed for universal application to all cancer survivors, yet some clinicians interviewed in the studies were uncertain how the standards would specifically move the needle for AYAs beyond their general applicability. Generating and disseminating standards, clinicians emphasized, is necessary but not sufficient; the harder task is making them change care for individual patients. Because AYAs represent a small fraction of adult cancer patients while facing decades of elevated risk and distinct medical, psychosocial, and financial concerns, institutions may need to adapt implementation by age group. The researchers suggest concrete examples: fertility preservation and restoration should be explicitly highlighted for AYAs with established referral pathways and identified financial assistance resources; insurance assessments should account for limited health insurance literacy and prepare survivors for coverage changes that coincide with life transitions, such as aging out of parental plans at 26; and psychosocial and financial screening should be age-appropriate enough to capture the realities of young adulthood.

The path forward, the authors argue, demands investment at both policy and research levels. Data infrastructure must be strengthened and data sharing enabled within and across health systems, because the same fragmentation that hampers research also hampers care coordination for a population that may change care sources multiple times across a lifetime. Linking health system data to population-based sources would allow evaluation of the standards at scale, though existing national resources such as SEER–Medicare cover only adults 65 and older and offer little for AYAs. Critically, future efforts must extend beyond academic centers into community oncology settings, where most AYAs actually receive their care, and into primary care, which is increasingly tasked with lifelong survivorship follow-up. And because AYA survivors are a relatively rare population, single-site studies—even at large centers—lack the sample size, diversity, and follow-up needed for meaningful longitudinal evaluation. Multisite collaborations, the researchers conclude, are the only realistic route to coordinated cohorts large enough to compare how the standards are measured and experienced across systems, and to test interventions that could finally translate a well-intentioned national framework into tangible, equitable care for young survivors.

Subject of Research: Assessing alignment of national cancer survivorship care standards for adolescent and young adult cancer survivors across US health systems

Article Title: Understanding and advancing alignment of the national standards for cancer survivorship care for adolescents and young adults: challenges and opportunities

Article References: AYA National Standards for Cancer Survivorship Care Consortium, Betts, A. C., Baker, K. S., Blaes, A. H., Devine, K. A., Hahn, E. E., Miller, K. A., Parsons, H. M., & Yi, J. C. (2026). Understanding and advancing alignment of the national standards for cancer survivorship care for adolescents and young adults: challenges and opportunities. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02128-9

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02128-9

Keywords: cancer survivorship, adolescent and young adult cancer, AYA oncology, National Standards for Cancer Survivorship Care, electronic health records, survivorship care delivery, health services research, patient-reported outcomes, fertility preservation, health insurance, care coordination, NCI-designated cancer centers

The research team, led by investigators at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine and collaborators at Thomas Jefferson University, set out to solve a problem that has quietly hindered the survivorship field for years. National organizations including the Institute of Medicine, the National Cancer Institute, and the American Society of Clinical Oncology have long called for survivorship care to become a routine component of high-quality cancer care, and the National Standards translated that aspiration into concrete domains: surveillance, symptom management, supportive services, care coordination, and patient-centered follow-up. But the standards describe what should be delivered, not whether an institution has the workflows, staffing models, referral pathways, and data systems to deliver it. Existing quality frameworks, such as Commission on Cancer Standard 4.8 metrics, the LIVESTRONG Center of Excellence indicators, and ASCO’s Quality Oncology Practice Initiative measures, function largely as checklists or compliance metrics rather than as staged assessments of organizational capability.

Maturity models offer a different lens. Borrowed from engineering and business process management, and increasingly applied in healthcare informatics, maturity models characterize progressive stages of organizational capability, from ad hoc improvisation to fully optimized, data-driven operation. Their value lies not merely in identifying strengths and weaknesses but in providing a roadmap: each successive level describes the concrete processes, resources, and governance an organization must build to advance. Until now, such frameworks had been minimally applied in cancer survivorship, a gap the CSMM was explicitly designed to fill. Crucially, the model assesses organizational capability for implementing the National Standards rather than directly measuring the quality of care itself, a distinction the authors emphasize throughout.

Building the model required a careful methodological translation. Because the ten National Standards define clinical services rather than implementation functions, the researchers could not simply map one standard to one maturity domain. Instead, they consolidated conceptually related standards that depend on shared organizational capabilities into seven broader operational domains: survivorship care planning, risk of recurrence, specialty care, financial hardship and toxicity, lifestyle behaviors and supportive services, practical and social impacts, and physical and psychological effects. For example, the standards addressing lifestyle behaviors and supportive health services were merged because both are typically operationalized through similar screening processes, referral pathways, navigation programs, and community partnerships. Each domain was then described across five maturity levels, adapted from established maturity model frameworks, ranging from level one, ad hoc, to level five, optimized, with descriptors reflecting observable institutional characteristics such as role delineation, documentation practices, and use of data.

To refine and test this preliminary strawman model, the team conducted a mixed-methods, participatory study anchored in five multidisciplinary focus groups at the comprehensive cancer center. Fourteen clinicians and supportive care professionals participated, drawn from oncology, primary care, nursing, social work, rehabilitation, and psychosocial services, and practicing across academic, safety-net, and Veterans Affairs settings. The sessions employed consensus-building techniques adapted from the nominal group technique, a structured approach designed to elicit expert perspectives while preventing any single voice from dominating. Participants completed dot-voting prioritization exercises, ranking the seven domains by three distinct criteria: which would have the greatest clinical impact if implemented, which would be easiest to implement, and which patients would prioritize most highly. They then revised maturity level descriptors and rated their own practice settings against the model.

The prioritization results exposed a striking tension at the heart of survivorship care implementation. Risk of recurrence, specialty care, and survivorship care planning ranked highest for both clinical impact and implementation ease, and these two dimensions correlated moderately with each other. But when participants considered what patients would prioritize most, the picture shifted dramatically toward physical and psychological effects, risk of recurrence, and financial hardship. Statistical analysis confirmed the divergence: clinical impact and perceived patient priority showed a weak negative correlation, with a Spearman’s rho of minus 0.252, and overall concordance across the three ranking dimensions was minimal, at a Kendall’s W of just 0.056. In practical terms, the domains clinicians view as most influential for outcomes are not the ones patients experience as most urgent, a mismatch with direct consequences for how institutions allocate scarce resources.

When participants applied the CSMM to their own settings, the results were uniformly humbling. Maturity ratings clustered between levels one and two, indicating that survivorship care processes remain largely ad hoc or, at best, planned rather than standardized and integrated. Risk of recurrence and specialty care scored relatively higher, suggesting that surveillance and referral activities embedded in routine oncology practice are more established, while lifestyle behaviors, supportive services, and practical and social impacts lagged furthest behind. Variation within the institution was substantial: specialty care ratings ranged from a mean of 1.00 in one focus group to 3.67 in another, revealing uneven development of capabilities even within a single cancer center. The model was then distributed to twelve external stakeholders affiliated with the National Cancer Institute Survivorship Supplement Awardees network, institutions that are among the most survivorship-engaged in the country. Their overall mean rating was 1.93, nearly identical to the internal mean of 1.85, a finding the authors describe as striking, since even these focused centers remain at early maturity stages.

Qualitative analysis of the focus group discussions illuminated why implementation stalls. The most frequently cited barrier, mentioned in five of the groups, was a lack of clearly defined processes and responsibilities, captured in one participant’s observation that there is a lack of workflow clarity about the process and roles. Clinician time constraints followed closely, then variation in survivorship needs across cancer types and settings, limited institutional resources, and technical barriers such as fragmented electronic health record integration. Participants noted that practical and social issues bleed into financial issues, complicating domain boundaries, and that survivorship care is resource-intensive yet rarely supported by dedicated funding or protected time. Importantly, they also identified opportunities: embedding patient-reported needs screening into clinic workflows and creating reliable referral triggers could advance maturity without requiring major new investment.

The CSMM is designed as a structured self-assessment rather than a scoring exercise. Organizations compare current practices against domain descriptors, select the level that best reflects their state, and receive a radar plot of their maturity profile overlaid with aggregate community averages. When completed by multiple stakeholders, divergent ratings are treated not as measurement error but as valuable signals of misalignment between clinical, administrative, and operational perspectives. The model can be administered at baseline and repeated over time to track progress, and the online assessment is publicly available for organizations implementing the National Standards. The authors acknowledge limitations, including the single-center origin of the focus groups, the modest external sample, and the absence of survivor and caregiver perspectives in this development phase, all of which they flag as priorities for future refinement.

The broader significance of the study lies in reframing the survivorship challenge. The field has largely succeeded in defining what good survivorship care looks like; what it has lacked is a way to ask whether institutions possess the organizational capability to provide it. By translating national standards into staged, domain-specific maturity levels, the CSMM gives program leaders, administrators, and clinicians a common language for identifying where processes break down and where the next dollar, hire, or workflow redesign will matter most. As the number of cancer survivors continues to grow and the National Standards evolve, tools of this kind may prove essential for converting well-intentioned national guidance into consistent, patient-centered care that reaches every survivor, not just those fortunate enough to land in a mature system.

Subject of Research: Development of the Cancer Survivorship Maturity Model to assess organizational implementation of the National Standards for Cancer Survivorship Care

Article Title: Supporting implementation of the national standards for cancer survivorship care: development of the cancer survivorship maturity model (CSMM)

Article References: Dowst, H., Shirzadi, M., Mims, M., Hilsenbeck, S., Wang, L., & Badr, H. (2026). Supporting implementation of the national standards for cancer survivorship care: development of the cancer survivorship maturity model (CSMM). Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02131-0

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02131-0

Keywords: cancer survivorship, maturity model, National Standards for Cancer Survivorship Care, implementation science, health care management, organizational maturity, oncology, nominal group technique, quality improvement, patient-centered care, health services research, survivorship care planning

The stakes of this gap are considerable. By 2040, an estimated 26 million people in the United States will be living with a history of cancer, and roughly 55 percent of them are expected to rely on unpaid family members or friends for medical, instrumental, and psychosocial support. Caregivers attend appointments, manage complex medication schedules, monitor treatment side effects at home, provide transportation, and absorb the emotional fallout of a cancer diagnosis, often for years at a time. Previous research cited in the study estimates that about 42 percent of cancer caregivers experience depression, 46 percent experience anxiety, and a quarter face financial strain, underscoring that caregiving is not merely a supporting role but a demanding health exposure in its own right.

The National Standards for Cancer Survivorship Care were designed in part to change this picture. They require that health systems have a process to collect data on caregivers’ experiences and unmet needs, formally recognizing caregivers as part of the care team. But the standards do not specify which experiences should be assessed or how, and until now there has been little evidence about whether the standard is being met in practice. The new study, led by Abigayle R. Feather, Marguerite A. Webster, Jessica L. Burris, and Laurie E. McLouth of the University of Kentucky Markey Cancer Center, set out to measure that gap directly, asking caregivers themselves how often their concerns were raised, heard, and addressed.

The research team conducted a cross-sectional, convergent mixed-methods study at an NCI-Designated Comprehensive Cancer Center. Seventy-seven caregivers of survivors with solid tumors completed a survey; participants were recruited from breast, gynecologic, head and neck, and multidisciplinary outpatient clinics, with survivors either at least three months into active treatment or attending post-treatment survivorship care. The investigators purposively sampled to obtain relatively even distributions across treatment phase and disease stage. Caregivers ranged in age from 24 to 84, with a mean of about 55 years; roughly 65 percent were female, 96 percent were non-Hispanic White, and nearly 60 percent lived in rural areas, defined using the 2023 USDA Rural-Urban Continuum Codes. Most were spouses or adult children of the survivor, and on average they reported providing nearly 36 hours of care per week.

The survey instrument was deliberately structured to mirror the survivor assessment domains in the national standards, supplemented with caregiving-specific concerns from prior research. Caregivers were asked how often, since diagnosis, the cancer treatment team had asked about emotional strain, physical problems, social concerns, and challenges in providing medical and non-medical care, using items adapted from the Patient Centered Survivorship Index. They also completed the Caregiver Roles and Responsibilities Scale, a validated measure spanning support, lifestyle, emotional health, self-care, and financial well-being. Eight caregivers then completed semi-structured interviews, which were analyzed using directed content analysis anchored to the national standards, with initial coding agreement exceeding 80 percent.

The quantitative results were stark. Emotional concerns were the most commonly reported, at 66 percent, followed by physical concerns at 32 percent and caregiving-specific medical and non-medical task concerns at about 22 percent. Yet across every domain, at least half of caregivers said the care team had never asked about the relevant issue. Among those who did experience a concern, 14 percent or fewer said they had raised it with the care team, and fewer than 6 percent of those with physical, social, or non-medical caregiving concerns reported communicating them at all. The interview data corroborated the survey: caregivers described being asked about the survivor’s needs frequently, but their own needs were assessed rarely, if ever, with supportive care information often delivered as printed material early in treatment that required caregivers to follow up on their own initiative.

Subgroup comparisons revealed few statistically significant differences, but one pattern stood out clearly. Rural caregivers were significantly less likely than non-rural caregivers to report that the care team asked at least half the time about their social concerns, 8.7 percent versus 23.3 percent, and about medical caregiving-related concerns, 19.6 percent versus 30 percent. The authors suggest that care teams may default to discussing logistical barriers such as transportation with rural families while overlooking emotional and medical caregiving needs, or that rural caregivers’ well-documented barriers to disclosure, including stigma around seeking help and cultural values of self-reliance, may suppress conversations. With more than 20 percent of U.S. cancer caregivers living in rural areas, and evidence that rural caregivers often have more unmet needs than their care recipients, the authors argue that systematic assessment could help level this inequity.

The interviews also mapped the practical terrain caregivers navigate. Barriers inside the health system included physically navigating sprawling hospital campuses and parking, coordinating care across multiple specialists, and communication lapses that left caregivers feeling their concerns were not fully appreciated. Outside the system, distance from the cancer center, transportation, financial limitations, insurance challenges, difficulty taking family leave, and poor coordination between the cancer center and local clinics all impeded access to support. Facilitators included approachable providers, effective interdisciplinary coordination, supportive care services integrated into treatment, insurance coverage, charitable assistance, and local availability of certain services. Caregivers offered concrete recommendations: more personalized information delivery, including videos on topics such as post-surgical care, proactive outreach with relevant resources, caregiver support groups, and tangible help such as meal coupons for families spending long days at the hospital.

The authors are candid about the study’s limitations. The sample was predominantly White, educated, and relatively affluent, so findings may not generalize to caregivers with fewer socioeconomic resources who face additional barriers. The single-site design, self-reported measures subject to recall and social desirability bias, and a small qualitative sample of eight interviews all constrain interpretation. The study also relied on caregiver reports rather than auditing formal health system processes, and because the national standards do not prescribe specific caregiver assessment procedures, the findings should be read as informing potential approaches rather than evaluating fidelity to a mandated model. Still, as one of the first studies to assess alignment with the new standards from the caregiver perspective, it offers a template for how systems might begin collecting the data the standards require.

The implications reach beyond any single institution. The authors argue that cancer care should implement routine, comprehensive, structured assessment of caregiver concerns paralleling survivor assessment, paired with standardized referral pathways to on-site and local services, education about those services, and navigation support to reduce barriers to use. Existing care delivery initiatives, including distress screening and tobacco screening, may offer adaptable frameworks, and implementation science approaches such as the Fit-to-Context Framework and co-creation with multilevel partners could help ensure procedures are feasible and sustainable. Until caregiver burden is recognized in diagnostic and billing codes, reimbursement barriers will continue to limit access to services, making policy change essential. The deeper shift the study calls for is conceptual: reframing the survivor and caregiver together as the unit of care in oncology, so that the people doing much of the work of cancer care are no longer invisible to the system that depends on them.

Subject of Research: Caregiver experiences and unmet needs in cancer survivorship care relative to the National Standards for Cancer Survivorship Care

Article Title: The national standards for cancer survivorship care in action: caregiver experiences across stage, phase, and geography

Article References: Feather, A. R., Webster, M. A., Stanek, M. L., Andreae, L. J., Back-Haddix, S., Blair, C., Burris, J. L., & McLouth, L. E. (2026). The national standards for cancer survivorship care in action: caregiver experiences across stage, phase, and geography. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02124-z

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02124-z

Keywords: cancer caregivers, cancer survivorship, National Standards for Cancer Survivorship Care, caregiver burden, unmet needs, rural health disparities, supportive care, distress screening, mixed methods, care delivery, quality of life, health system assessment

The numbers behind that roadmap are staggering. In 2025, an estimated 18.6 million people in the United States were living as cancer survivors, a figure projected to climb to 26 million by 2040. Roughly two million new diagnoses are made annually, and with five-year survival rates now at 70 percent and ten-year survival at 48 percent, caring for the long-term physical, psychological, social, and functional consequences of cancer has become a central challenge of modern oncology. Yet implementation of evidence-based survivorship care has lagged. Nationwide surveys show that only about 31 percent of Commission on Cancer accredited facilities and 41 percent of NCI Community Oncology Research Program institutions operate dedicated survivorship clinics, leaving most care to already stretched treatment teams with limited survivorship specialization.

The new study, led by Marguerite A. Webster and colleagues at the University of Kentucky Markey Cancer Center, is among the first to measure how clinical practice aligns with the national standards directly from the survivor’s perspective. The researchers conducted a convergent mixed-methods investigation at a university-based NCI Designated Comprehensive Cancer Center in the southeastern United States, combining standardized surveys with semi-structured interviews. Between February and August 2025, 150 survivors recruited from four outpatient solid tumor clinics completed roughly 30-minute surveys. Participants ranged in age from 22 to 83, with a mean of about 59 years, and were purposively sampled to ensure balanced representation across treatment phase, disease stage, and rural versus nonrural residence. A subset of 17 survivors then completed in-depth interviews averaging 24 minutes, which were analyzed using directed content analysis anchored to the national standards.

The survey instrument, modeled on the Patient-Centered Survivorship Care Index, asked participants how often their care team asked about six domains of concern: physical, emotional, practical, social, financial, and insurance. Survivors were counted as assessed only if they reported being asked at most or every visit, reflecting the standards’ expectation that survivors be evaluated at multiple points across their care. The results revealed a striking hierarchy of attention. Physical concerns topped the list, with 91 percent of participants reporting regular assessment, followed by tobacco use at 87 percent, physical activity at 79 percent, emotional concerns at 79 percent, and diet at 74 percent. Financial hardship fell to 29 percent and insurance concerns to 22 percent, making money-related matters the least screened domains by a wide margin.

Encouragingly, once a concern was voiced, the care system largely delivered. Among survivors who reported experiencing and communicating a concern, management through advice, help, or referral was nearly universal: 97 percent for physical concerns, 96 percent for emotional concerns, and a full 100 percent for financial, insurance, and social concerns. Lifestyle behaviors fared somewhat less well, with diet advice reaching 94 percent of those asked but tobacco counseling only 70 percent. The pattern suggests the fundamental machinery of referral and support exists within the cancer center; the bottleneck is not the response but the question. Concerns that survivors never mention—because no one asks—are concerns the system never addresses.

That bottleneck appears to fall unevenly on already vulnerable populations. Rural survivors in the sample reported significantly lower rates of assessment for physical concerns (89 percent versus 97 percent) and financial concerns (23 percent versus 38 percent) compared with nonrural peers, and were less likely to say they were listened to about practical and social matters. They were also less likely to be asked about diet, physical activity, and alcohol use. The authors speculate that care teams may assume rural patients prefer not to discuss personal financial matters, an unspoken cultural assumption that risks leaving financial toxicity undetected where it may be most severe. By contrast, treatment phase and disease stage made little difference in screening practices, with one notable exception: 96 percent of actively treated survivors received help with practical concerns such as transportation, compared with none of the post-treatment survivors.

The interviews added texture to these statistics. Survivors described assessments that were often generic—repeated questions like “Is there anything you need?”—rather than structured, focused screening beyond routine check-ins about pain and depression. Symptom and wellbeing questionnaires were frequently administered through the patient portal or by nursing staff before appointments, with inconsistent follow-up by physicians. Many participants were unaware that the cancer center offered dedicated survivorship visits at all, and few recalled being offered a meeting with a survivorship nurse after finishing treatment. When problems were identified, however, survivors praised the care teams’ responsiveness, describing multidisciplinary referrals to social workers, nutritionists, genetic counselors, and physical therapists, and emphasizing the value of approachable providers who practiced genuine shared decision-making. As one participant put it, “I’m not a number. They actually care.”

The financial blind spot carries real consequences. Financial toxicity—the hardship caused by the cost of medical care—affects between 28 and 48 percent of cancer survivors and is associated with active treatment, late-stage diagnosis, and longer time since diagnosis. It is tightly intertwined with insurance problems, employment disruption, and mounting debt, and it can delay or derail treatment in ways that directly worsen outcomes. Paradoxically, national studies of NCI Community Oncology Research Program and NCCN sites report that 72 to 78 percent of institutions claim to have financial screening processes in place, yet other research shows 58 percent of breast cancer survivors were never asked about financial stressors by their care team. Policy and process, in other words, do not guarantee reach. The authors argue that even where screening mandates exist, implementation may fail at the individual patient level—particularly for rural and other underserved survivors.

The solution, the researchers contend, cannot rest on patients’ willingness to advocate for themselves. Social determinants such as insurance coverage, travel distance, and financial hardship can disrupt care delivery and degrade cancer outcomes, so the onus should fall on the health system. They recommend proactive, standardized assessment of financial and insurance concerns at multiple points in care, expanded access to financial navigation, empathetic provider communication about money, and periodic audits to verify that screening tools are actually working. Cancer centers should also operationalize the national standards into clearly defined steps and benchmarks, since the standards currently describe important processes but offer little guidance for measurement. Quality improvement frameworks such as Plan-Do-Study-Act cycles could help institutions implement the standards systematically, with special focus on financial matters.

The study has limitations worth noting. It measured only a subset of the standards’ process indicators, relied on self-reported data vulnerable to recall and social desirability bias, used face-valid survey items rather than psychometrically validated instruments, and drew its sample from a single cancer center, limiting generalizability. The interview subset of 17 participants was small, and qualitative findings should be read as an expansion of survey results rather than a definitive population portrait. Still, as one of the first direct assessments of the new national standards from survivors’ own experiences, the work delivers an unambiguous message: the health system has learned to ask about the body and the mind, but until it routinely asks about the wallet, survivorship care will remain incomplete for millions of Americans facing cancer’s long financial shadow.

Subject of Research: Assessment of financial and insurance concerns in cancer survivorship care under the 2024 National Standards for Cancer Survivorship Care

Article Title: Financial concerns: a critical gap in survivors’ experience of the implementation of the national standards for cancer survivorship care

Article References: Financial concerns: a critical gap in survivors’ experience of the implementation of the national standards for cancer survivorship care. (n.d.). https://doi.org/10.1007/s11764-026-02126-x

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02126-x

Keywords: cancer survivorship, financial toxicity, National Standards for Cancer Survivorship Care, health insurance concerns, rural health disparities, mixed-methods research, survivorship care standards, financial screening, quality improvement, oncology care delivery, NCI Comprehensive Cancer Center, patient-reported outcomes